These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 29770053)

  • 1. Tuberculosis drug resistance in Canada: 2006-2016.
    Gallant V; Vachon J; Siu W
    Can Commun Dis Rep; 2017 Nov; 43(11):236-241. PubMed ID: 29770053
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tuberculosis drug resistance in Canada: 2018.
    LaFreniere M; Dam D; Strudwick L; McDermott S
    Can Commun Dis Rep; 2020 Jan; 46(1):9-15. PubMed ID: 31930215
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tuberculosis drug resistance in Canada: 2017.
    LaFreniere M; Hussain H; Vachon J
    Can Commun Dis Rep; 2018 Nov; 44(11):290-296. PubMed ID: 30996691
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A summary of tuberculosis drug resistance in Canada, 2003-2013.
    McGuire M; Gallant V; Bourgeois AC; Ogunnaike-Cooke S
    Can Commun Dis Rep; 2015 Mar; 41(Suppl 2):8-15. PubMed ID: 31713535
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evolution of Extensively Drug-Resistant Tuberculosis over Four Decades: Whole Genome Sequencing and Dating Analysis of Mycobacterium tuberculosis Isolates from KwaZulu-Natal.
    Cohen KA; Abeel T; Manson McGuire A; Desjardins CA; Munsamy V; Shea TP; Walker BJ; Bantubani N; Almeida DV; Alvarado L; Chapman SB; Mvelase NR; Duffy EY; Fitzgerald MG; Govender P; Gujja S; Hamilton S; Howarth C; Larimer JD; Maharaj K; Pearson MD; Priest ME; Zeng Q; Padayatchi N; Grosset J; Young SK; Wortman J; Mlisana KP; O'Donnell MR; Birren BW; Bishai WR; Pym AS; Earl AM
    PLoS Med; 2015 Sep; 12(9):e1001880. PubMed ID: 26418737
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The burden of pre-extensively and extensively drug-resistant tuberculosis among MDR-TB patients in the Amhara region, Ethiopia.
    Shibabaw A; Gelaw B; Gebreyes W; Robinson R; Wang SH; Tessema B
    PLoS One; 2020; 15(2):e0229040. PubMed ID: 32053661
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tuberculosis in Canada: 1924-2012.
    Gallant V; Ogunnaike-Cooke S; McGuire M
    Can Commun Dis Rep; 2014 Mar; 40(6):99-107. PubMed ID: 29769890
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antimicrobial use and antimicrobial resistance trends in Canada: 2014.
    Ebrahim M; Gravel D; Thabet C; Abdesselam K; Paramalingam S; Hyson C
    Can Commun Dis Rep; 2016 Nov; 42(11):227-231. PubMed ID: 29769991
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Detection of Second Line Drug Resistance among Drug Resistant Mycobacterium Tuberculosis Isolates in Botswana.
    Mogashoa T; Melamu P; Derendinger B; Ley SD; Streicher EM; Iketleng T; Mupfumi L; Mokomane M; Kgwaadira B; Rankgoane-Pono G; Tsholofelo TT; Kasvosve I; Moyo S; Warren RM; Gaseitsiwe S
    Pathogens; 2019 Oct; 8(4):. PubMed ID: 31661825
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Drug resistance among tuberculosis cases in the European Union and European Economic Area, 2007 to 2012.
    van der Werf MJ; Ködmön C; Hollo V; Sandgren A; Zucs P
    Euro Surveill; 2014 Mar; 19(10):. PubMed ID: 24650865
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Worldwide emergence of extensively drug-resistant tuberculosis.
    Shah NS; Wright A; Bai GH; Barrera L; Boulahbal F; Martín-Casabona N; Drobniewski F; Gilpin C; Havelková M; Lepe R; Lumb R; Metchock B; Portaels F; Rodrigues MF; Rüsch-Gerdes S; Van Deun A; Vincent V; Laserson K; Wells C; Cegielski JP
    Emerg Infect Dis; 2007 Mar; 13(3):380-7. PubMed ID: 17552090
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Low Levels of Extensively Drug-resistant Tuberculosis among Multidrug Resistant Tuberculosis Isolates and Their Relationship to Risk Factors: Surveillance in Tehran, Iran; 2006 to 2014.
    Tasbiti AH; Yari S; Ghanei M; Shokrgozar MA; Fateh A; Bahrmand A
    Osong Public Health Res Perspect; 2017 Apr; 8(2):116-123. PubMed ID: 28540155
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Multidrug and extensively drug-resistant tuberculosis in Canada 1997-2008: demographic and disease characteristics.
    Minion J; Gallant V; Wolfe J; Jamieson F; Long R
    PLoS One; 2013; 8(1):e53466. PubMed ID: 23326436
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mycobacterial interspersed repetitive unit typing and mutational profile for multidrug-resistant and extensively drug-resistant tuberculosis surveillance in Portugal: a 3-year period overview.
    Silva C; Perdigão J; Jordão L; Portugal I
    Int J Antimicrob Agents; 2014 Dec; 44(6):546-51. PubMed ID: 25270633
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Analysis of drug resistance and mutation profiles in
    Zhang J; Ren Y; Pan L; Yi J; Guan T; Yang X; Zhang Z
    J Int Med Res; 2021 Jan; 49(1):300060520984932. PubMed ID: 33461383
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Investigation of extensive drug resistance in multidrug resistance tuberculosis isolates].
    Bektöre B; Haznedaroğlu T; Baylan O; Ozyurt M; Ozkütük N; Satana D; Cavuşoğlu C; Seber E
    Mikrobiyol Bul; 2013 Jan; 47(1):59-70. PubMed ID: 23390903
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genotyping and clinical characteristics of multidrug and extensively drug-resistant tuberculosis in a tertiary care tuberculosis hospital in China.
    Yuan X; Zhang T; Kawakami K; Zhu J; Zheng W; Li H; Deng G; Tu S; Liu W
    BMC Infect Dis; 2013 Jul; 13():315. PubMed ID: 23849244
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Spoligotype-based comparative population structure analysis of multidrug-resistant and isoniazid-monoresistant Mycobacterium tuberculosis complex clinical isolates in Poland.
    Jagielski T; Augustynowicz-Kopec E; Zozio T; Rastogi N; Zwolska Z
    J Clin Microbiol; 2010 Nov; 48(11):3899-909. PubMed ID: 20810763
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Isolation of Mycobacterium tuberculosis from sputum of tribal, non-tribal pulmonary tuberculosis patients of Andaman & Nicobar islands by conventional culture method and assessment of first line anti-tuberculosis drug susceptibility patterns.
    Mandal A; Parthasarathy G; Burma SP; Sugunan AP; Vijayachari P
    Indian J Tuberc; 2015 Jan; 62(1):23-8. PubMed ID: 25857562
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Tuberculosis Laboratory Surveillance Network (TuLSA) study group. The first step for national tuberculosis laboratory surveillance: Ankara, 2011].
    Sezen F; Albayrak N; Özkara Ş; Karagöz A; Alp A; Duyar Ağca F; İnan Süer A; Müderris T; Ceyhan İ; Durmaz R; Ertek M;
    Mikrobiyol Bul; 2015 Apr; 49(2):143-55. PubMed ID: 26167815
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.